Remit
To advise the Commission established under Section 2 of the Medicines Act on the following in relation to human medicines including herbal products:
- the public health importance of potential new signals
- the confirmation and quantification of risks identified
- appropriate risk minimisation measures including communications
- design and progress of pharmacovigilance plans
- methodologies for pharmacovigilance.
Membership
Chair
* Professor Munir Pirmohamed MB ChB (Hons) PhD FRCP FRCP(E)
Professor of Clinical Pharmacology, University of Liverpool, NHS Chair of Pharmacogenetics and Director of the Wolfson Centre for Personalised Medicine
Members
+ Dr Robert C G Bracchi BSc MB Bch MD FRCGP
General Practitioner and Honorary Lecturer, University of Wales
Dr Jamie Coleman ChB MD MA (Med Ed) MRCP(UK)
Senior Lecturer in Clinical Pharmacology, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham
Dr William Dixon Bsc MBBS MRCP MSc (Clin Rheum) PhD (epid) MSc (pharmepid)
MRC Clinician Scientist/Senior Clinical Lecturer & Honorary Consultant Rheumatologist, University of Manchester
Dr Ian J Douglas BSc MSc PhD
Lecturer in Pharmacoepidemiology, London School of Hygiene & Tropical Medicine
Miss Alison B Ewing BSc MSc MIPharmM FRPharmS
Clinical Director of Pharmacy Royal Liverpool and Broadgreen University Hospital NHS Trust
Professor David Gunnell MB ChB MRCGP PhD MSc FFPHM
Professor of Epidemiology, University of Bristol
Ms Jane Harris MSc BN RN RM RHV DN
Programme Manager for Modernising Nursing in the Community, Scottish Government/Senior Lecturer University of Dundee
Professor Simon R J Maxwell MD FRCP FRCPE FB Pharmacol.S FHEA
Professor of Student Learning/Clinical Pharmacology, Western General Hospital, Edinburgh and University of Edinburgh
Dr Karen Miller BSc, MBBS, DRCOG, DCH, DFFP, MRCGP
GP Partner at Adelaide Medical Centre, London
Dr Nicholas J Plant BSc PhD
Senior Lecturer in Molecular Toxicology, University of Surrey
Professor Alan Silman MSc MD FRCP FFPHM FMedSci
Medical Director of the Arthritis Research Campaign
Dr Ruben Thanacoody MD FRCP(Edin)
Consultant Physician and Clinical Toxicologist, Royal Victoria Infirmary, Newcastle-upon-Tyne
Dr Caroline Vaughan BSc PhD
Lay Member of Hammersmith Hospitals Medical Research Ethics Committee; Director, Contact a Family; Trustee, Family Line Surrey
Professor Patrick Waller BMedSci MD MPH FRCP Ed. FFPM
Honorary Professor, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
Professor Ken Woodhouse MD FRCP FHEA
Professor of Medicine and Geriatric Medicine, Cardiff University
Mr Phil Willan MSc
Lay Representative. Member of the Patient Information and Cardiovascular, Diabetes, Renal, Respiratory and Allergy EAGs. Member of the Royal College of Physicians’ (RCP) Patient and Carer Network; Member of the RCP Joint Speciality Committee (JSC) for Renal Medicine, Healthcare Associated Infections Working Group, Specialist Advisory Committee for Renal Medicine, JSC for Allergy and Immunology, Faculty of Forensic and Legal Medicine, Federation CPD Policy Committee and Equality and Diversity Monitoring Committee.
* = Member of the Commission on Human Medicines
+ = Member of the Herbal Medicines Advisory Committee
Meeting dates
2012
| January | February | March | April | May | June |
|---|---|---|---|---|---|
| 11 | 8 | 7 | 11 | 16 | 13 |
| July | September | October | November | December | |
| 11 | 12 | 10 | 7 | 5 |

